期刊文献+

艾拉莫德对小鼠成纤维细胞分泌胶原的影响 被引量:4

The Effect of Iguratimod on the Collagen Secretion of 3T6 Cells.
下载PDF
导出
摘要 目的观察艾拉莫德对小鼠成纤维细胞3T6细胞分泌胶原的影响。方法利用MTT法得到艾拉莫德对3T6细胞的半数毒性浓度约为1142.6mg/L,最终给药浓度选取334.38mg/L(二甲基亚砜浓度为1μl/256μl)、167.4mg/L、83.7mg/L、41.85mg/L,并以未加药组作为空白对照,分别在给药后12h、24h、36h、48h取细胞上清,采用氯胺T法检测其中细胞分泌的胶原。结果药物浓度334.38mg/L组在给药后12h、24h、36h与空白对照组比较胶原浓度增大(P<0.05),167.4mg/L和83.7mg/L组在给药后24h、48h与空白对照组比较胶原浓度增大;41.85mg/L组在给药后12h、24h与空白对照组比较胶原浓度降低(P<0.05)。结论艾拉莫德对小鼠成纤维细胞3T6细胞分泌胶原的影响具有时间和药物浓度依赖性,高浓度可促进胶原的分泌,低浓度药物41.85 mg/L组可减少细胞胶原的分泌。 Objective To study the effect of Iguratimod on the collagen secretion of 3T6 cells. Method The median toxic concerttration of Iguratimod was determination by MTT Assay. Iguratimod' s median toxic concentration to 3T6 cell was about 1142.6mg/L. Taking into the consideration of the cells' performance after administration under spectacles, we chosen the administration concentration as 334.8 mg/L( DMSO : 1 μl/256μl) , 167.4mg/L,83.7mg/L and 41.85 mg/L. After administration of 12 hours, 24 hours, 36 hours and 48 hours, the supernatant was collected for assayed respectively. The collagens content was detected by the method of chloramine T. Results The collagen concentration of the drug concentration 334. 375mg/L group increased (P 〈 0.05) after 12 hours, 24 hours and 36 hours of administration in comparison with the normal blank group. After 48 hours, their collagen concentration decreased. The collagen concentration of group 167.4mg/L and group 83.7mg/L increased after 24 hours and 48 hours of administration in comparison with the normal blank group. The collagen concentration of group 41.85mg/L decreased after 12 hours and 24 hours of administration in comparison with the normal blank group(P 〈 0.05). Conclusion The effect of Iguratimod on the collagen secretion of 3T6 cells has a time - dependence and dose -dependence. The high concentration can promote the collagen secretion. The low concentration 41.85mg/L can reduce the col- lagen secretion.
出处 《医学研究杂志》 2009年第10期44-47,共4页 Journal of Medical Research
关键词 艾拉莫德 小鼠成纤维细胞 胶原 氯胺T法 Lguratimod 3T6 murine fibroblast Collagen The method of chloramine T
  • 相关文献

参考文献8

  • 1Aikawa Y, Tanuma N, Shin T,et al. A new anti- rheumatic drug, T - 614, effectively suppresses the development of autoimmune encephalomyelitis. J Neuroimmunol, 1998,89 ( 1 - 2) :35 - 42.
  • 2Tanaka K, Yamamoto T, Aikawa Y,et al. Inhibitory effects of an anti - rheumatic agent T -614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice. Rheumatology (Oxford) ,2003 ,42( 11 ) :1365 - 1371.
  • 3Futaki N, Yoshikawa K, Hamasaka Y,et al. NS -398, a novel non - steroidal anti - inflammatory drug with potent analgesic and antipyretie effects, which causes minimal stomach lesions. Gen Pharmaeol, 1993, 24(1) :105 -110.
  • 4舒强,李兴福,刘花香,李栋.类风湿关节炎滑膜成纤维样细胞增殖特性的体外研究[J].山东大学学报(医学版),2006,44(11):1095-1099. 被引量:7
  • 5Zamoiskii EA. Evaluation of Reed - Muench method in determination of activity of biological preparations. Zh Mikrobiol Epidemiol Immunohiol, 1956,27 ( 1 ) :77 - 83.
  • 6Leighton J, Estes LW, Goldblatt PJ, et al. The formation of histotypic fibrous collagen in matrix tissue culture by 3T6 mouse fibroblasts: a response to ascorbic acid. In Vitro,1970 ,6 (3) : 153 - 161.
  • 7Lories RJ, Derese I, De Bari C ,et al. In vitro growth rate of fibroblast - like synovial cells is reduced by methotrexate treatment. Ann Rheum Dis,2003,62(6) :568 - 571.
  • 8舒强,李兴福,侯怀水,李栋,刘花香.艾拉莫德对骨关节炎滑膜成纤维样细胞特性的影响[J].中华风湿病学杂志,2006,10(7):389-392. 被引量:17

二级参考文献21

  • 1舒强,李兴福,侯怀水,李栋,刘花香.艾拉莫德对骨关节炎滑膜成纤维样细胞特性的影响[J].中华风湿病学杂志,2006,10(7):389-392. 被引量:17
  • 2Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology(Oxford), 2005, 44: 7-16.
  • 3Fiorito S, Magrini L, Adrey J, et al. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. Rheumatology (Oxford),2005, 44: 164-171.
  • 4Benito MJ, Veale DJ, Fitz-Gerald O, et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis, 2005, 64:1263-1267.
  • 5Lories RJU, Derese I, De Bari C, et al. In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment.Ann Rheum Dis, 2003, 62: 568-571.
  • 6Aikawa Y, Yamamoto M, Yamamoto T, et al. An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS-and TNF-alpha-stimulated THP-1 cells without interfering with Ikappa B-alpha degradation. Inflamm Res, 2002, 51: 188-194.
  • 7Tanaka K, Yamamoto T, Aikawa Y, et al. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice. Rheumatology (Oxford), 2003, 42: 1365-1371.
  • 8Inaba T, Tanaka K, Takeno R, et al. Synthesis and antiinflammatory activity of 7-methanesulfonylamino-6-phenoxychromones:antiarthritic effect of the 3-formylamino compound (T-614) in chronic inflammatory disease models. Chem Pharm Bull (Tokyo),2000, 48: 131-139.
  • 9Kawakami A, Tsuboi M, Urayama S, et al. Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells. J Lab Clin Med, 1999, 133: 566-574.
  • 10Kohno M, Aikawa Y, Tsubouchi Y, et al. Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cytokine production and nuclear factor-kappa B activation in cultured human synovial cells. J Rheumatol, 2001, 28: 2591-2596.

共引文献20

同被引文献46

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部